- Rally Could 'Have Some Legs in 2010': Market Strategist
- Investors May Skew Housing Reality
- Buffett's Wealth and Fame Hasn't Helped 'Warren' As a Name
- Are Crazy Retail Deals Good for Business?
- Expect a 'Square Root-Shaped' Recovery: Chief Investor
- Madoff—The Holiday Drink
- HP to Feed on Enterprise Spending Next Year: Tech Analyst
- Busch: Markets Smell a Country Rat
- Schork Oil Outlook: Mission Impossible For The Bears?
- Bear, Lehman Execs Weren't Wiped Out by Crisis: Study
- How Real Estate Investors Skew Housing's Reality
- Even Buffett's Huge Fame Can't Help the Name 'Warren'
- Wave of Debt Payments Facing US Government
- US Job Losses to Bottom out Next Quarter: NABE
- Obama Jobs Forum May Be More Political Than Practical
- Maria Blog: Are Crazy Retail Deals Good for Business?
- Suze Orman’s 'A Healthier, Wealthier You'
- Latest Holiday Drinks: The Madoff...and the TARPatini
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Existing-Home Sales Jump To Highest Level in 2-1/2 Years
- Wave of Debt Payments Facing US Government
- Paul: Audit the Fed
- Start-Up Proves Everything Really Is Better With Bacon
- TV Retailer QVC Joins 'Black Friday' Frenzy
- Buffett's Wealth and Fame Hasn't Helped 'Warren' As a Name
- S&P Stocks Trading at New 52-Week Highs
- Madoff—The Holiday Drink
- China Asks Its Banks to Slow Down
Text Size 
 |
Pfizer [PFE
Loading...
()
]fired McKinnell as CEO last July and stripped him of his chairmanship 2 months earlier than expected this week. But according to this SEC filing posted on the web after the market close yesterday, McKinnell is none the worse for the wear.
The company he worked at for nearly 4 decades and ran for about 5 years says it won't see revenue growth until at least 2009. (It's cutting billions of dollars in costs, letting thousands of employees go - and that was before the loss of a key developmental drug earlier this month, so it could even get worse.) But Hank McKinnell will be sitting pretty. Pfizer shares fell about 40% on McKinnell's watch. They've risen about 3 bucks since around the time he was ousted.
Pfizer says McKinnell is getting an $82 million pension. (He can get one big fat check or draw a whole bunch of relatively smaller ones over several years.) He has $78 million in deferred compensation coming to him. That's money he earned but let ride for example in Pfizer stock.
And then McKinnell will get another $39 million in severance bonuses and other cash and stock including compensation for vacation time he did not use. The total value of his additional time on the clock - more than $300,000 for a grand total of $199 million.
In a research note to clients this morning Miller Tabak Healthcare Analyst Les Funtleyder figures the exit package works out to "A little over $2 million for every billion dollars in market cap lost during his tenure."
He says "Though this will receive some media attention, we view this as more annoying than material."
A Pfizer spokesman says the company is fulfilling its legal obligation to honor the terms of McKinnell's contract which was signed in 2001 - what he called a "Different time in the company's history". He says he doesn't know if McKinnell has told Pfizer how he wants his money, whether he'll take it all at once or spread it out.
- The show attracts a big TV audience every year, but this year it may take on even more importance.
- …you'll want to be prepared. Tips for getting the most out of the post-Thanksgiving shopping frenzy.
- Congressman Ron Paul explains to Squawk Box why he’s pushing legislation to audit the Federal Reserve.
- CNBC’s Phil LeBeau took a test drive of GM’s flagship electric car. Here’s what he thought of the Volt.
- A Macau casino will open Asia's first Michael Jackson shrine after its owners made a key purchase at a US auction.
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.
Data is a real-time snapshot *Data is delayed at least 15 minutes